(Q44022859)

29 November 2017

title

Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin (English)

1 reference

29 November 2017

1 reference

coronary artery disease

1 reference

7

Gerald M Reaven

1 reference

29 November 2017

Bernard Cantin

1

1 reference

29 November 2017

Dening Zhu

2

1 reference

29 November 2017

Peizhong Wen

3

1 reference

29 November 2017

Shyam N Panchal

4

1 reference

29 November 2017

Xiaohong Dai

5

1 reference

29 November 2017

Judith K Gwathmey

6

1 reference

29 November 2017

Hannah A Valantine

8

1 reference

29 November 2017

publication date

1 June 2002

1 reference

The Journal of Heart and Lung Transplantation

29 November 2017

published in

1 reference

29 November 2017

volume

21

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

637-643

1 reference

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Diabetes and dyslipidemia. A new model for transplant coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

1 reference

7 January 2021

Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Considerations regarding the contributions of B cells to chronic allograft rejection in experimental animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: patterns and contributing factors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Metformin improves vascular function in insulin-resistant rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

The influence of hypoglycaemic agents on the growth and metabolism of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction. Histopathological analysis using a retransplantation model

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Management of cardiac allograft vasculopathy by transmyocardial laser revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Transmyocardial laser revascularization in allograft coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Effects of pravastatin on chronic rejection of rat cardiac allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900768-9

7 January 2021

10.1016/S1053-2498(01)00768-9

Identifiers

DOI

1 reference

29 November 2017

1 reference